Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2863 (LINC02863)

Target
LINC02863
Molecular classification
Long intergenic non-coding RNA (lincRNA), Long non-coding RNA (lncRNA), Other (non-coding RNA)
01

Overview

LINC02863 (long intergenic non-protein coding RNA 2863) is a human long intergenic non-coding RNA gene encoding RNA transcripts longer than 200 nucleotides that do not overlap annotated protein-coding genes[1][5][7]. Long intergenic non-coding RNAs (lincRNAs) like LINC02863 are a subset of long non-coding RNAs distinguished by their position in the genome and lack of protein-coding potential. Although many lincRNAs have regulatory roles such as modulating chromatin structure, regulating transcription, or acting as enhancers, only a small fraction have been functionally characterized to date. There is currently no published information describing the specific biological function, disease association, or therapeutic relevance of LINC02863.

Other names
LINC02863Long intergenic non-protein coding RNA 2863
02

Mechanism of action

None known. No mechanisms of action for drug targeting of LINC02863 have been described.

03

Biological functions

Other (No specific function described for LINC02863; general lincRNA functions include chromatin remodeling, transcription regulation, enhancer-associated activity, and fine-tuning gene expression with tissue specificity[1][5].)
04

Disease associations

Other (No disease association or specific role of LINC02863 is reported. Generally, lincRNAs may play roles in cancer, immune response, cell cycle, and other diseases, but LINC02863's involvement is not described[1][5].)
05

Safety considerations

None known. There are no notable safety concerns or therapeutic challenges associated with LINC02863.
06

Interacting drugs

None known. No drugs are reported to interact with LINC02863.
07

Biomarkers

None known. There is no evidence that LINC02863 is used as a biomarker for patient selection or efficacy monitoring.

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2863 (LINC02863).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2863 (LINC02863).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call